Tag: fulvestrant

Genentech’s Phase 3 study of inavolisib in breast cancer reveals positive results

businessnewstoday- December 9, 2023

Genentech, part of the Roche Group, has presented compelling results from the Phase III INAVO120 study, evaluating the effectiveness of inavolisib in combination with palbociclib ... Read More

Roche’s inavolisib meets primary endpoint of PFS in Phase 3 breast cancer trial

businessnewstoday- December 6, 2023

Roche, a global leader in pharmaceuticals, announced positive results from its Phase III INAVO120 study, testing the investigational therapy inavolisib in combination with palbociclib (Ibrance) ... Read More

Ibrance FDA approval : Pfizer breast cancer drug approved for metastatic breast cancer in men

pharmanewsdaily- April 17, 2019

New Ibrance FDA approval : The US Food and Drug Administration (FDA) has extended the approval of Pfizer breast cancer drug Ibrance (palbociclib) to cover ... Read More

Lilly’s breast cancer drug abemaciclib meets objective in phase 3 trial

pharmanewsdaily- March 22, 2017

Indianapolis-based Lilly has reported that its breast cancer drug, abemaciclib, in combination with fulvestrant, has yielded positive results by meeting its primary endpoint, progression-free survival ... Read More